SCHEMBL1127089

SCHEMBL1127089

COCCCn1cc(-c2ccccc2)cc1C

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GLO1 Q04760 2/20 0.42
ALDH1A1 P00352 2/20 0.40
HPGD P15428 1/20 0.38
CNR1 P21554 2/20 0.38
BRD4 O60885 1/20 0.38
CNR2 P34972 1/20 0.38
ADORA2A P29274 1/20 0.36
ADORA2B P29275 1/20 0.36
MAPK1 P28482 2/20 0.36
RAB9A P51151 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
GRM4 Q14833 1/20 0.35
TRPV4 Q9HBA0 1/20 0.35
CECR2 Q9BXF3 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1127207 0.95 GLO1 (0.39) GLO1ALDH1A1HPGDCNR1BRD4
SCHEMBL1126990 0.90 CNR1 (0.45) GLO1ALDH1A1HPGDCNR1BRD4
SCHEMBL1126944 0.85 KDM4E (0.41) HPGDBRD4MAPK1RAB9ANPC1
SCHEMBL1127094 0.82 TYR (0.49) GLO1ALDH1A1HPGDCNR1BRD4
SCHEMBL1126707 0.80 BRD4 (0.42) ALDH1A1HPGDCNR1BRD4LMNA
SCHEMBL1988099 0.80 BRD4 (0.37) GLO1ALDH1A1HPGDCNR1BRD4
SCHEMBL1126929 0.78 TYR (0.46) ALDH1A1BRD4CNR2ADORA2B
SCHEMBL1127015 0.78 RAB9A (0.49) ALDH1A1MAPK1RAB9ANPC1
SCHEMBL1126844 0.78 KDM4E (0.46) ALDH1A1CNR1BRD4MAPK1RAB9A
SCHEMBL1127357 0.77 BRD4 (0.37) ALDH1A1CNR1BRD4RAB9ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9452168-B2 Pyrrole antifungal agents F2G LTD (GB) 2016-09-27 US disclosed
US-20150238500-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2015-08-27 US disclosed
US-8993574-B2 Pyrrole antifungal agents F2G LTD (GB) 2015-03-31 US disclosed
EP-2283006-B1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2015-02-25 EP disclosed
EP-2626361-B1 Pyrrole antifungal agents F2G LTD (GB) 2014-10-15 EP disclosed
EP-2626361-A1 Pyrrole antifungal agents F2G Limited (GB) 2013-08-14 EP disclosed
US-20110152285-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2011-06-23 US disclosed
EP-2283006-A1 PYRROLE ANTIFUNGAL AGENTS F2G Limited (GB) 2011-02-16 EP disclosed
WO-2009130481-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2009-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152285-A1 PYRROLE ANTIFUNGAL AGENTS FOXM1, PYCR1, ARG1 GLO1 113/4885ALDH1A1 219/4885HPGD 2971/4885
US-20150238500-A1 PYRROLE ANTIFUNGAL AGENTS FOXM1, PYCR1, ARG1 GLO1 113/4885ALDH1A1 219/4885HPGD 2971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.